ConductScience.org, home

Paper16622207

Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.

Walther M and 18 others. Infect Immun, 2006. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein. Papers, record 16622207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16622207

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.
PubMed
Journal
Infect Immun
PubMed
Year
2006
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
1.29
iCite
Revised in PubMed
2025-05-29
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Walther MMichael
2Thompson FMFiona M
3Dunachie SSusanna
4Keating SSheila
5Todryk SStephen
6Berthoud TTamara
7Andrews LLaura
8Andersen RFRikke F
9Moore AAnne
10Gilbert SCSarah C
11Poulton IIan
12Dubovsky FFilip
13Tierney EEveline
14Correa SSimon
15Huntcooke AAngela
16Butcher GGeoffrey
17Williams JJack
18Sinden RERobert E
19Hill AVAdrian V S

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Malaria VaccinesMajor topic
Plasmodium falciparumMajor topic
Protozoan ProteinsMajor topic
Vaccines, SyntheticMajor topic
Adult
Animals
Antibodies, Protozoan
Clinical Trials as Topic
Glycosylphosphatidylinositols
Humans
Immunization, Secondary
Interferon-gamma
Parasitemia
Poxviridae
Vaccinia virus

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
G84/6323Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References44

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115315836Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif.Vaccine2004https://conductscience.org/library/papers/15315836PubMed
21703674Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children.Trans R Soc Trop Med Hyg1990https://conductscience.org/library/papers/1703674PubMed
315655787
Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites.
J Infect Dis2005https://conductscience.org/library/papers/15655787PubMed
416014857Quantitative real-time polymerase chain reaction for malaria diagnosis and its use in malaria vaccine clinical trials.Am J Trop Med Hyg2005https://conductscience.org/library/papers/16014857PubMed
59862371Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I-restricted epitope with recombinant carriers suitable for human use.Eur J Immunol1998https://conductscience.org/library/papers/9862371PubMed
614978115Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus.J Immunol2004https://conductscience.org/library/papers/14978115PubMed
7808142Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites.Am J Trop Med Hyg1975https://conductscience.org/library/papers/808142PubMed
815865223Therapeutic vaccination of HIV-1-infected patients on HAART with a recombinant HIV-1 nef-expressing MVA: safety, immunogenicity and influence on viral load during treatment interruption.Antivir Ther2005https://conductscience.org/library/papers/15865223PubMed
911747915Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.Lancet2001https://conductscience.org/library/papers/11747915PubMed
1012766765Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.Nat Med2003https://conductscience.org/library/papers/12766765PubMed
1111183752Malaria. A renewed assault on an old and deadly foe.Science2000https://conductscience.org/library/papers/11183752PubMed
126057225Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.Nature1967https://conductscience.org/library/papers/6057225PubMed
1314604567Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals.Vaccine2003https://conductscience.org/library/papers/14604567PubMed
1411241272
Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP-specific Th2 type immune responses and improvesprotection against malaria infection.
Eur J Immunol2001https://conductscience.org/library/papers/11241272PubMed
1515361247Does malaria suffer from lack of memory?Immunol Rev2004https://conductscience.org/library/papers/15361247PubMed
1615034567A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.Nat Med2004https://conductscience.org/library/papers/15034567PubMed
1711803063Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.Vaccine2002https://conductscience.org/library/papers/11803063PubMed
182464643Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria.J Immunol1989https://conductscience.org/library/papers/2464643PubMed
1911393868Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.Science2001https://conductscience.org/library/papers/11393868PubMed
2016488059Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.Vaccine2006https://conductscience.org/library/papers/16488059PubMed

See all 44 referencesDownload CSV of references

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
34930178Reproducibility of malaria sporozoite challenge model in humans for evaluating efficacy of vaccines and drugs: a systematic review.BMC Infect Dis2021https://conductscience.org/library/papers/34930178PubMed
29083948Chimpanzee adenoviral vectors as vaccines for outbreak pathogens.Hum Vaccin Immunother2017https://conductscience.org/library/papers/29083948PubMed
28923897Controlled Human Malaria Infection: Applications, Advances, and Challenges.Infect Immun2018https://conductscience.org/library/papers/28923897PubMed
26511884Recombinant modified vaccinia virus Ankara-based malaria vaccines.Expert Rev Vaccines2016https://conductscience.org/library/papers/26511884PubMed
25853483The evolution of poxvirus vaccines.Viruses2015https://conductscience.org/library/papers/25853483PubMed
25522180A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS.PLoS One2014https://conductscience.org/library/papers/25522180PubMed
25336730Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.J Infect Dis2015https://conductscience.org/library/papers/25336730PubMed
251408894-1BBL enhances CD8+ T cell responses induced by vectored vaccines in mice but fails to improve immunogenicity in rhesus macaques.PLoS One2014https://conductscience.org/library/papers/25140889PubMed
24575238Induction of an Antibody Response against Plasmodium falciparum F2RIIEBA by Heterologous Prime-boost Immunisation.Trop Life Sci Res2013https://conductscience.org/library/papers/24575238PubMed
23733037Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines.Hum Vaccin Immunother2013https://conductscience.org/library/papers/23733037PubMed
23710439Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research.Biomed Res Int2013https://conductscience.org/library/papers/23710439PubMed
23583893Reflections on the early development of poxvirus vectors.Vaccine2013https://conductscience.org/library/papers/23583893PubMed
22701640Comparison of clinical and parasitological data from controlled human malaria infection trials.PLoS One2012https://conductscience.org/library/papers/22701640PubMed
22403305Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials.Am J Trop Med Hyg2012https://conductscience.org/library/papers/22403305PubMed
22363582Phase Ia clinical evaluation of the safety and immunogenicity of the Plasmodium falciparum blood-stage antigen AMA1 in ChAd63 and MVA vaccine vectors.PLoS One2012https://conductscience.org/library/papers/22363582PubMed
22348325Bacterium-like particles as multi-epitope delivery platform for Plasmodium berghei circumsporozoite protein induce complete protection against malaria in mice.Malar J2012https://conductscience.org/library/papers/22348325PubMed
22230255A review of malaria vaccine clinical projects based on the WHO rainbow table.Malar J2012https://conductscience.org/library/papers/22230255PubMed
21603645Dual neonate vaccine platform against HIV-1 and M. tuberculosis.PLoS One2011https://conductscience.org/library/papers/21603645PubMed
21179119Experimental human challenge infections can accelerate clinical malaria vaccine development.Nat Rev Immunol2011https://conductscience.org/library/papers/21179119PubMed
21123952Advances and challenges in malaria vaccine development.J Clin Invest2010https://conductscience.org/library/papers/21123952PubMed

See all 31 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16622207

GET https://conductscience.org/api/papers/v1/16622207/references?page=2